Locksley works to zero in on rare earths source in the shadow of the Mountain Pass mine
Special Report: A follow-up work program has kicked off on high-grade rare earth elements (REEs) on the north block of Locksley’s Mojave project in California, USA.
Locksley Resources (ASX:LKY) is chasing valuable rare earth opportunities at its Mojave project, a stone’s throw from the USA’s only operating rare earths mine, Mountain Pass, which accounts for 15% of global supply.
Mojave sits in the shadow of Mountain Pass with mapping and sampling in the September quarter returning 12.1% (122,338 ppm) Total Rare-Earth Oxide (TREO) rock chips from the El Campo prospect.
That’s an exceptionally high grade for rare earths.
The sample also returned 3.19% NdPr, the critical, highly valuable magnet rare earths used in EV motors, wind turbines, medical devices and even ammunition.
Multiple REE targets have been identified across the northern block at Mojave following a field program undertaken in August which identified six catchment areas as prospective for ongoing REE exploration.
The previously reported results represent a new area of REE potential amongst Mojave’s north block (which abuts Mountain Pass), a large area of 164 claims totalling 14.9km² and highlights the potential for additional high-grade REE mineralisation.
LKY has now kicked off follow up sampling at these catchment areas and believes the program holds the potential to identify additional high-grade rare earths within the broader Mojave project area.
“The stream sediment sampling program completed at the north block previously returned assays ranging from 0.103% to 0.26% TREO, highlighting the prospectivity for further REE discoveries in the north block claims,” Locksley managing director Steve Woodham says.
“The company remains well funded and looks forward to reporting the results of the current program as soon as practicable.”
This article was developed in collaboration with Locksley Resources, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.